Form 4 filed by NELSEN ROBERT
NELSEN ROBERT filed this Form 4 on CITY THERAPEUTICS, INC. with 8 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-19 21:37:43 UTC.
- Accession
- 0001104659-26-116965
- Filer
- CIK 1219042
- Filed
- 2026-10-19
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: CITY THERAPEUTICS, INC. (CIK 2143850)
- NELSEN ROBERT director, 10% owner
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-19 | C converted | +3,294,900 | 6,013,192 | I By ARCH Venture Fund XII, L.P. | |
| Common Stock | 2026-10-19 | C converted | +5,482,309 | 11,495,501 | I By ARCH Venture Fund XII, L.P. | |
| Common Stock | 2026-10-19 | C converted | +2,027,006 | 13,522,507 | I By ARCH Venture Fund XII, L.P. | |
| Common Stock | 2026-10-19 | P bought | +170,000 | $18 | 13,692,507 | I By ARCH Venture Fund XII, L.P. |
| Stock Option (Right to Buy) derivative | 2026-10-15 | A granted | +22,649 | $0 | 22,649 | D |
| Series Seed convertible preferred stock derivative | 2026-10-19 | C converted | -3,000,000 | $0 | 0 | I By ARCH Venture Fund XII, L.P. |
| Series A convertible preferred stock derivative | 2026-10-19 | C converted | -4,991,633 | $0 | 0 | I By ARCH Venture Fund XII, L.P. |
| Series B convertible preferred stock derivative | 2026-10-19 | C converted | -1,845,585 | $0 | 0 | I By ARCH Venture Fund XII, L.P. |